Literature DB >> 8932446

The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins.

K Okimoto1, R A Rajewski, K Uekama, J A Jona, V J Stella.   

Abstract

PURPOSE: The objective of this work was to determine the role that charge might play in the interaction of charged and uncharged drugs with neutral (2-hydroxypropyl-beta-cyclodextrin, HP-beta-CD) and anionically charged (SBE7-beta-CD) modified beta-cyclodextrins. SBE7-beta-CD is a sulfobutyl ether, sodium salt, derivative variably substituted on the 2-, 3- and the 6-positions of beta-cyclodextrin. The number seven refers to the average degree of substitution.
METHODS: The binding of the acidic drugs, indomethacin, naproxen and warfarin and the basic drugs, papaverine, thiabendazole, miconazole and cinnarizine with the two cyclodextrins was determined at 25 degrees C as a function of pH and cyclodextrin concentration by the phase-solubility method.
RESULTS: Except for miconazole and cinnarizine (Ap-type diagrams), all other materials studied displayed AL-type diagrams. By comparing the binding constants of both the charged and uncharged forms of the same drugs to both HP-beta-CD and SBE7-beta-CD, the following conclusions could be drawn. The binding constants for the neutral forms of the drugs were always greater with SBE7-beta-CD than with HP-beta-CD. For the anionic agents, the binding constants between SBE7-beta-CD and HP-beta-CD were similar while the binding constants for the cationic agents with SBE7-beta-CD were superior to those of HP-beta-CD, especially when compared with the neutral form of the same drug.
CONCLUSIONS: A clear charge effect on complexation, attraction in the case of cationic drugs and perhaps inhibition in the case of anionic drugs, was seen with the SBE7-beta-CD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932446     DOI: 10.1023/a:1016047215907

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  High-field nuclear magnetic resonance techniques for the investigation of a beta-cyclodextrin:indomethacin inclusion complex.

Authors:  F Djedaïni; S Z Lin; B Perly; D Wouessidjewe
Journal:  J Pharm Sci       Date:  1990-07       Impact factor: 3.534

2.  Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state.

Authors:  T Tokumura; H Ueda; Y Tsushima; M Kasai; M Kayano; I Amada; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-10       Impact factor: 1.645

3.  Effect of cycloamyloses on apparent dissociation constants of carboxylic acids and phenols: equilibrium analytical selectivity induced by complex formation.

Authors:  K A Connors; J M Lipari
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

4.  beta-cyclodextrin derivatives, SBE4-beta-CD and HP-beta-CD, increase the oral bioavailability of cinnarizine in beagle dogs.

Authors:  T Järvinen; K Järvinen; N Schwarting; V J Stella
Journal:  J Pharm Sci       Date:  1995-03       Impact factor: 3.534

5.  Potentiometric study of molecular complexes of weak acids and bases applied to complexes of alpha-cyclodextrin with para-substituted benzoic acids.

Authors:  K A Connors; S F Lin; A B Wong
Journal:  J Pharm Sci       Date:  1982-02       Impact factor: 3.534

6.  Characterization of sulphoalkyl ether derivatives of beta-cyclodextrin by capillary electrophoresis with indirect UV detection.

Authors:  R J Tait; D J Skanchy; D P Thompson; N C Chetwyn; D A Dunshee; R A Rajewski; V J Stella; J F Stobaugh
Journal:  J Pharm Biomed Anal       Date:  1992-09       Impact factor: 3.935

7.  Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives.

Authors:  R A Rajewski; G Traiger; J Bresnahan; P Jaberaboansari; V J Stella; D O Thompson
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

8.  Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro.

Authors:  K Shiotani; K Uehata; T Irie; K Uekama; D O Thompson; V J Stella
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

9.  Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-beta-cyclodextrin.

Authors:  A Y Tinwalla; B L Hoesterey; T X Xiang; K Lim; B D Anderson
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

10.  Sulfobutyl ether beta-cyclodextrin (SBE-beta-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits.

Authors:  T Järvinen; K Järvinen; A Urtti; D Thompson; V J Stella
Journal:  J Ocul Pharmacol Ther       Date:  1995       Impact factor: 2.671

View more
  21 in total

1.  Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.

Authors:  Ketan Hippalgaonkar; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

2.  Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.

Authors:  K Okimoto; A Ohike; R Ibuki; O Aoki; N Ohnishi; T Irie; K Uekama; R A Rajewski; V J Stella
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

3.  Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.

Authors:  Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

4.  Cocrystal Solubility Product Prediction Using an in combo Model and Simulations to Improve Design of Experiments.

Authors:  Alex Avdeef
Journal:  Pharm Res       Date:  2018-02-02       Impact factor: 4.200

5.  Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD.

Authors:  V Zia; R A Rajewski; V J Stella
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

6.  Solubility-excipient classification gradient maps.

Authors:  Alex Avdeef; Stefanie Bendels; Oksana Tsinman; Konstantin Tsinman; Manfred Kansy
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

7.  Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.

Authors:  K Okimoto; M Miyake; N Ohnishi; R A Rajewski; V J Stella; T Irie; K Uekama
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

8.  The influence of cosolvent on the complexation of HP-beta-cyclodextrins with oleanolic acid and ursolic acid.

Authors:  Rui Li; Peng Quan; Dong-Fei Liu; Fang-Di Wei; Qing Zhang; Qun-Wei Xu
Journal:  AAPS PharmSciTech       Date:  2009-10-16       Impact factor: 3.246

9.  Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms.

Authors:  J Savolainen; K Järvinen; H Taipale; P Jarho; T Loftsson; T Järvinen
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

10.  Acyclic Cucurbit[n]uril-Type Molecular Containers: Influence of Linker Length on Their Function as Solubilizing Agents.

Authors:  David Sigwalt; Damien Moncelet; Shane Falcinelli; Vijaybabu Mandadapu; Peter Y Zavalij; Anthony Day; Volker Briken; Lyle Isaacs
Journal:  ChemMedChem       Date:  2016-03-15       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.